Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 2Phase 1/2 1

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Neoplasm Metastasis 2Liver Neoplasms 2Colorectal Neoplasms 2Glioma 1Glioblastoma 1Astrocytoma 1

Interventions

Bevacizumab 23Sorafenib 20Doxorubicin 14Gemcitabine 11durvalumab 10Oxaliplatin 10Fluorouracil 10Cisplatin 10Capecitabine 9Nivolumab 8pembrolizumab 6Sunitinib 6tremelimumab 5atezolizumab 5Radiofrequency Ablation 5Neoadjuvant Therapy 5Leucovorin 5lenvatinib 4aldesleukin 4Thalidomide 4Radiotherapy 4Radiosurgery 4Everolimus 4Erlotinib Hydrochloride 4Drug Therapy 4Carboplatin 4toripalimab 3regorafenib 3camrelizumab 3apatinib 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Liver Neoplasms × Talaporfin × Clear all
NCT00083785 2007-04-11

Study of the Litxâ„¢ System Combined With Chemotherapy in Patients With Colorectal Liver Metastases

Light Sciences LLC

Phase 2 Completed
25 enrolled
Gastrointestinal

Liver Neoplasms, Neoplasm Metastasis, Colorectal Neoplasms

NCT00068068 2006-09-19

Photodynamic Therapy With Talaporfin Sodium (LS11) in Treating Patients With Refractory Colorectal Liver Metastases

Light Sciences LLC

Phase 2 Completed
25 enrolled
Gastrointestinal

Liver Neoplasms, Neoplasm Metastasis, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡